-
Uncategorized1 month agoSTAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies
Over the last five years, German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment, showing that CAR-T therapy...
-
Uncategorized1 month ago
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
After two rejections, Replimune has made it across the regulatory finish line with its twice-rejected therapy for advanced melanoma. Meanwhile, the last of the major pharmas,...
-
Uncategorized1 month ago
Why a missed promotion isn’t always about you
A missed promotion can feel like a verdict on your potential. But people and organizations do not always develop at the same pace. Executive coach Angela...
-
Uncategorized1 month ago
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
-
Uncategorized1 month ago
Steroid Curbs Chronic Lung Inflammation Without Weakening Immune Defenses
Nontuberculous mycobacterial infections have become an increasing concern for people with chronic lung disease, in part because the infections can linger despite months of antibiotic treatment....
-
Uncategorized1 month ago
Glucose-responsive probiotics for glycaemic modulation in mice and monkeys
Post Content
-
Uncategorized1 month ago
Author Correction: Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models
Nature Biotechnology, Published online: 12 August 2026; doi:10.1038/s41587-026-03281-3 Author Correction: Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models
-
Uncategorized1 month agoStopping statins in people over 75 at low risk for heart disease didn’t increase deaths
Not long after guidelines shifted to considering statin therapy as early as age 30, new research from France suggests there may be no harm in stopping...
-
Uncategorized1 month ago
Parasite-Specific Protein Helps Toxoplasma Adapt to Crowded Conditions
Toxoplasma gondii is a parasite that infects hundreds of millions of people around the world. Although cases are often mild, it can cause severe symptoms in...
-
Uncategorized1 month agoThe State of Biotech 2026
John Maraganore, PhD Co-Founder and Executive ChairCity Therapeutics View Bio Panelist John Maraganore, PhD John Maraganore, PhD, is a co-founder and executive chair of City Therapeutics....
FDA clears first generic radioligand drug; Sionna turns to layoffs
WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight
Ensuring safety and accountability in China’s biomedical translation system
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
